linkedin
BROUGHT TO YOU BY
Exclusive Access, Inclusive Growth

WELCOME TO ET PRIME

BROUGTH TO YOU BY
Exclusive Access, Inclusive Growth

Pharma

1
Pharma

Clutching at straws, policymakers back hydroxychloroquine use in contagion battle. Safety, see you later.

Faced with a race against time, India’s top medical-research body has given the go-ahead to use hydroxychloroquine, an antiparasitic agent for malaria treatment, for prophylactic use among frontline healthcare workers. While physicians caution that this may be an ill-thought move, pharma manufacturers are sniffing opportunity.

headset AUDIO SUMMARY . 01:28
Pharma

Clutching at straws, policymakers back hydroxychloroquine use in contagion battle. Safety, see you later.

Faced with a race against time, India’s top medical-research body has given the go-ahead to use hydroxychloroquine, an antiparasitic agent for malaria treatment, for prophylactic use among frontline healthcare workers. While physicians caution that this may be an ill-thought move, pharma manufacturers are sniffing opportunity.

headset AUDIO SUMMARY . 01:28
Pharma

Kill, escape, strike again: how wily viruses are becoming a nightmare for vaccine companies

A vaccine takes at least 24 months to develop. But in that time, the virus it is supposed to tackle may have mutated, enabling it to attack the immune system differently. Although faster gene sequencing has helped shorten development timelines, there are regulatory hurdles also to be cleared. And above all, sustained commercial viability poses the toughest challenge.

[[^message]]

Result

[[/message]] [[#message]]

[[message]]

[[/message]]